These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3723485)

  • 1. Use and misuse of the term potency with respect to oral contraceptives.
    Goldzieher JW
    J Reprod Med; 1986 Jun; 31(6 Suppl):533-9. PubMed ID: 3723485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestational potency of oral contraceptives.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jan; 47(1):106-12. PubMed ID: 1246375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rationale for prescribing oral contraceptives].
    Teichmann AT
    Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological assay of progestinics and antiprogestinics].
    Chambon Y
    Therapie; 1968; 23(4):703-35. PubMed ID: 4314722
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral contraceptives in 1984.
    Chapler EK
    Iowa Med; 1984 Oct; 74(10):439-40, 442. PubMed ID: 6490338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestational activity of a new diacetate progesterone derivative.
    Vázquez E; Arias J; Alvarez M
    J Reprod Med; 1970 Aug; 5(2):84-9. PubMed ID: 5521774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of oral contraceptives and the risk of breast cancer.
    Webster L
    J Reprod Med; 1986 Jun; 31(6 Suppl):540-5. PubMed ID: 3723486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives.
    de la Rey N; Schall R; Luus HG; Meyer BH; Müller FO
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):435-9. PubMed ID: 8225692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of progestins in contraception.
    Erkkola R; Landgren BM
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):207-16. PubMed ID: 15715527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The androgenicity of progestational agents.
    Lobo RA
    Int J Fertil; 1988; 33 Suppl():6-12. PubMed ID: 2908040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.